Living donor liver transplant recipients achieve relatively higher immunosuppressant blood levels than cadaveric recipients

Liver Transplantation

Volumn 8, Issue 3, 2002, Pages 212-218

  Trotter, James F ^a   Stolpman, Nancy ^b   Wachs, Michael ^b   Bak, Thomas ^a   Kugelmas, Marcelo ^a   Kam, Igal ^b   Everson, Gregory T ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; STEROID; TACROLIMUS;

ARTICLE; CADAVER DONOR; COHORT ANALYSIS; CONTROLLED STUDY; DISTRIBUTION VOLUME; DRUG BLOOD LEVEL; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER REGENERATION; LIVER TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECIPIENT; STATISTICAL ANALYSIS;

EID: 0036199456     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1053/jlts.2002.31346     Document Type: Article

References (34)

1. Single-center analysis of the first 40 adult-to-adult living donor liver transplants using the right lobe
2. Adult-to-adult living donor liver transplant using rightlobe grafts: Results and lessons learned from a single-center experience
3. Living donor liver transplantation in adults: Outcome in Europe
4. Living donor liver transplantation in adults: Outcome in Japan
5. Living donor liver transplantation in hepatitis C patients: Short-term results compared to cadaveric transplantation
6. Differences in cellular rejection rates between living donor and cadaveric liver transplant recipients
7. A critical analysis of tacrolimus dosing requirements and concentrations in living donor liver transplant recipients
8. Tacrolimus dosage adjustment n adult right lobe liver transplant recipients
9. Increased immunosuppressive levels in hepatitis C liver transplant recipients receiving sirolimus
10. The effect of biliary enteroenterostomy on the pharmacokinetics of enterally administered cyclosporine in rats
11. Using cyclosporine (Neoral) immediately after liver transplantation
12. An open-label study of the safety and tolerability of converting stable liver transplant recipients to Neoral
13. Body mass index as a predictor of hepatic steatosis in living liver donors
14. Liver regeneration in recipients and donors after transplantation
15. Changes in graft volume after living-related liver transplantation
16. Liver regeneration and function in donor and recipient after right lobe adult to adult living donor liver transplantation
17. Small-for-size liver transplanted into larger recipient: A model of hepatic regeneration
18. Rapid growth of an intact human liver transplanted into a recipient larger than the donor
19. The hepatotropic influence of cyclosporine
20. Hepatotrophic effects of FK506 in dogs
21. Increased galactose clearance after liver transplantation: A measure of increased blood flow through the denervated liver?
22. Experimental pathology of the liver: Restoration of the liver of the white rat following partial surgical removal
23. Dynamics of normal and injured human liver regeneration after hepatectomy as assessed on the basis of computed tomography and liver function
24. Evaluation of liver volume and liver function following hepatic resection in man
25. Liver regeneration and restoration of liver function after partial hepatectomy in patients with liver tumors
26. Indocyanine green clearance and ammonia tolerance in partially hepatectomized and hepatic devascularized, anesthetized dogs
27. Regulation of renal cytochrome P450: Effects of 2/3 hepatectomy, cholestasis, biliary cirrhosis and post-necrotic cirrhosis on hepatic and renal microsomal enzymes
28. Changes in quantitative measures of hepatic function after 90% hepatectomy in rats
29. Inhibition of cytochrome P450 (P4503A) gene expression during liver regeneration from 2/3 hepatectomy in the rat
30. The induction of drug-metabolizing enzymes in rat liver during growth: A biochemical and ultrastructural study
31. The metabolism of drugs by regenerating liver
32. Differential effects of partial hepatectomy on hepatic and renal heme and cytochrome P450 metabolism
33. Selective changes in cytochrome P-450 and UDP-glucoronosyltransferase subpopulations following partial hepatectomy in rats
34. Expression of messenger RNA for liver functions following 70% and 90% hepatectomy